The main goal of our grants is to advance treatments for LGMD2I. In direct relation to our strategy, our grants typically fall into the following areas:


  • Basic research on limb girdle muscular dystrophy 2I and dystroglycanopathies in general
  • Generation of research tools
  • Translational Research/ Pre-clinical development of promising drug candidates
  • Development of biomarkers and outcome measures to be used in clinical trials
  • Identification of LGMD2I patients


All grants are reviewed in-house by LGMD2I Research Fund staff and scientific/medical advisors (grants are not reviewed by academic scientists, in order to avoid any conflict of interest).


Applying for grants

Awarded Grants